Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 13 to 24 of 1532 entries
Sorted by: Best Match Show Resources per page
Embryo quality and implantation rates are not influenced by total motile count values in an ICSI programme: a novel point of view.

International journal of molecular epidemiology and genetics

Hershko-Klement A, Rovner E, Yekutieli D, Ghetler Y, Gonen O, Cohen I, Wiser A, Berkovitz A, Shulman A.
PMID: 23050051
Int J Mol Epidemiol Genet. 2012;3(3):205-12. Epub 2012 Aug 31.

Total motile count (TMC) is a useful tool for sperm evaluation, comprising both quantitative and motility parameters. Although frequently used, TMC has not yet been evaluated as a contributory variable for intracytoplasmic sperm injection (ICSI) cycles. In this study...

Cite
Hershko-Klement A, Rovner E, Yekutieli D, et al. Embryo quality and implantation rates are not influenced by total motile count values in an ICSI programme: a novel point of view. Int J Mol Epidemiol Genet. 2012;3(3):205-12
Hershko-Klement, A., Rovner, E., Yekutieli, D., Ghetler, Y., Gonen, O., Cohen, I., Wiser, A., Berkovitz, A., & Shulman, A. (2012). Embryo quality and implantation rates are not influenced by total motile count values in an ICSI programme: a novel point of view. International journal of molecular epidemiology and genetics, 3(3), 205-12.
Hershko-Klement, Anat, et al. "Embryo quality and implantation rates are not influenced by total motile count values in an ICSI programme: a novel point of view." International journal of molecular epidemiology and genetics vol. 3,3 (2012): 205-12.
Hershko-Klement A, Rovner E, Yekutieli D, Ghetler Y, Gonen O, Cohen I, Wiser A, Berkovitz A, Shulman A. Embryo quality and implantation rates are not influenced by total motile count values in an ICSI programme: a novel point of view. Int J Mol Epidemiol Genet. 2012;3(3):205-12. Epub 2012 Aug 31. PMID: 23050051; PMCID: PMC3459219.
Copy Download .nbib Format: NLM
Graphene-to-substrate energy transfer through out-of-plane longitudinal acoustic phonons.

Nano letters

Chen IJ, Mante PA, Chang CK, Yang SC, Chen HY, Huang YR, Chen LC, Chen KH, Gusev V, Sun CK.
PMID: 24559107
Nano Lett. 2014 Mar 12;14(3):1317-23. doi: 10.1021/nl404297r. Epub 2014 Mar 03.

Practically, graphene is often deposited on substrates. Given the major substrate-induced modification of properties and considerable energy transfer at the interface, the graphene-substrate interaction has been widely discussed. However, the proposed mechanisms were restricted to the two-dimensional (2D) plane...

Cite
Chen IJ, Mante PA, Chang CK, et al. Graphene-to-substrate energy transfer through out-of-plane longitudinal acoustic phonons. Nano Lett. 2014;14(3):1317-23doi: 10.1021/nl404297r.
Chen, I. J., Mante, P. A., Chang, C. K., Yang, S. C., Chen, H. Y., Huang, Y. R., Chen, L. C., Chen, K. H., Gusev, V., & Sun, C. K. (2014). Graphene-to-substrate energy transfer through out-of-plane longitudinal acoustic phonons. Nano letters, 14(3), 1317-23. https://doi.org/10.1021/nl404297r
Chen, I-Ju, et al. "Graphene-to-substrate energy transfer through out-of-plane longitudinal acoustic phonons." Nano letters vol. 14,3 (2014): 1317-23. doi: https://doi.org/10.1021/nl404297r
Chen IJ, Mante PA, Chang CK, Yang SC, Chen HY, Huang YR, Chen LC, Chen KH, Gusev V, Sun CK. Graphene-to-substrate energy transfer through out-of-plane longitudinal acoustic phonons. Nano Lett. 2014 Mar 12;14(3):1317-23. doi: 10.1021/nl404297r. Epub 2014 Mar 03. PMID: 24559107.
Copy Download .nbib Format: NLM
Protein synthesis in cells isolated from the developing rat cerebellum.

International journal of developmental neuroscience : the official journal of the International Society for Developmental Neuroscience

Patel NJ, Cohen J, Balazs R.
PMID: 24874043
Int J Dev Neurosci. 1984;2(3):287-99. doi: 10.1016/0736-5748(84)90023-6.

The rate of protein synthesis was estimated in structurally preserved perikaryal preparations from 8-day-old rat cerebellum under conditions which overcome the problems of intracellular compartmentation. The rates were lower than the in vivo estimates at comparable ages, but they...

Cite
Patel NJ, Cohen J, Balazs R. Protein synthesis in cells isolated from the developing rat cerebellum. Int J Dev Neurosci. 1984;2(3):287-99doi: 10.1016/0736-5748(84)90023-6.
Patel, N. J., Cohen, J., & Balazs, R. (1984). Protein synthesis in cells isolated from the developing rat cerebellum. International journal of developmental neuroscience : the official journal of the International Society for Developmental Neuroscience, 2(3), 287-99. https://doi.org/10.1016/0736-5748(84)90023-6
Patel, N J, et al. "Protein synthesis in cells isolated from the developing rat cerebellum." International journal of developmental neuroscience : the official journal of the International Society for Developmental Neuroscience vol. 2,3 (1984): 287-99. doi: https://doi.org/10.1016/0736-5748(84)90023-6
Patel NJ, Cohen J, Balazs R. Protein synthesis in cells isolated from the developing rat cerebellum. Int J Dev Neurosci. 1984;2(3):287-99. doi: 10.1016/0736-5748(84)90023-6. PMID: 24874043.
Copy Download .nbib Format: NLM
A phase II/III randomized study to compare the efficacy and safety of rigosertib plus gemcitabine versus gemcitabine alone in patients with previously untreated metastatic pancreatic cancer.

Annals of oncology : official journal of the European Society for Medical Oncology

O'Neil BH, Scott AJ, Ma WW, Cohen SJ, Aisner DL, Menter AR, Tejani MA, Cho JK, Granfortuna J, Coveler AL, Olowokure OO, Baranda JC, Cusnir M, Phillip P, Boles J, Nazemzadeh R, Rarick M, Cohen DJ, Radford J, Fehrenbacher L, Bajaj R, Bathini V, Fanta P, Berlin J, McRee AJ, Maguire R, Wilhelm F, Maniar M, Jimeno A, Gomes CL, Messersmith WA.
PMID: 26945010
Ann Oncol. 2016 Jun;27(6):1180. doi: 10.1093/annonc/mdw095. Epub 2016 Mar 03.

No abstract available.

Cite
O'Neil BH, Scott AJ, Ma WW, et al. A phase II/III randomized study to compare the efficacy and safety of rigosertib plus gemcitabine versus gemcitabine alone in patients with previously untreated metastatic pancreatic cancer. Ann Oncol. 2016;27(6):1180doi: 10.1093/annonc/mdw095.
O'Neil, B. H., Scott, A. J., Ma, W. W., Cohen, S. J., Aisner, D. L., Menter, A. R., Tejani, M. A., Cho, J. K., Granfortuna, J., Coveler, A. L., Olowokure, O. O., Baranda, J. C., Cusnir, M., Phillip, P., Boles, J., Nazemzadeh, R., Rarick, M., Cohen, D. J., Radford, J., Fehrenbacher, L., Bajaj, R., Bathini, V., Fanta, P., Berlin, J., McRee, A. J., Maguire, R., Wilhelm, F., Maniar, M., Jimeno, A., Gomes, C. L., & Messersmith, W. A. (2016). A phase II/III randomized study to compare the efficacy and safety of rigosertib plus gemcitabine versus gemcitabine alone in patients with previously untreated metastatic pancreatic cancer. Annals of oncology : official journal of the European Society for Medical Oncology, 27(6), 1180. https://doi.org/10.1093/annonc/mdw095
O'Neil, B H, et al. "A phase II/III randomized study to compare the efficacy and safety of rigosertib plus gemcitabine versus gemcitabine alone in patients with previously untreated metastatic pancreatic cancer." Annals of oncology : official journal of the European Society for Medical Oncology vol. 27,6 (2016): 1180. doi: https://doi.org/10.1093/annonc/mdw095
O'Neil BH, Scott AJ, Ma WW, Cohen SJ, Aisner DL, Menter AR, Tejani MA, Cho JK, Granfortuna J, Coveler AL, Olowokure OO, Baranda JC, Cusnir M, Phillip P, Boles J, Nazemzadeh R, Rarick M, Cohen DJ, Radford J, Fehrenbacher L, Bajaj R, Bathini V, Fanta P, Berlin J, McRee AJ, Maguire R, Wilhelm F, Maniar M, Jimeno A, Gomes CL, Messersmith WA. A phase II/III randomized study to compare the efficacy and safety of rigosertib plus gemcitabine versus gemcitabine alone in patients with previously untreated metastatic pancreatic cancer. Ann Oncol. 2016 Jun;27(6):1180. doi: 10.1093/annonc/mdw095. Epub 2016 Mar 03. PMID: 26945010; PMCID: PMC6795379.
Copy Download .nbib Format: NLM
A Mammary-type Myofibroblastoma of the Prostate: A Case Report.

Urology case reports

Cohen AJ, Steele GS.
PMID: 27500086
Urol Case Rep. 2016 Jul 20;8:44-6. doi: 10.1016/j.eucr.2016.06.005. eCollection 2016 Sep.

We report the case of a 51-year-old gentleman presenting with obstructive and irritative urinary symptoms, found to have a large prostate mass on imaging. A radical prostatectomy was performed and pathological diagnosis revealed a 12 cm mammary-type myofibroblastoma replacing...

Cite
Cohen AJ, Steele GS. A Mammary-type Myofibroblastoma of the Prostate: A Case Report. Urol Case Rep. 2016;8:44-6doi: 10.1016/j.eucr.2016.06.005.
Cohen, A. J., & Steele, G. S. (2016). A Mammary-type Myofibroblastoma of the Prostate: A Case Report. Urology case reports, 844-6. https://doi.org/10.1016/j.eucr.2016.06.005
Cohen, Aaron J, and Steele, Graeme S. "A Mammary-type Myofibroblastoma of the Prostate: A Case Report." Urology case reports vol. 8 (2016): 44-6. doi: https://doi.org/10.1016/j.eucr.2016.06.005
Cohen AJ, Steele GS. A Mammary-type Myofibroblastoma of the Prostate: A Case Report. Urol Case Rep. 2016 Jul 20;8:44-6. doi: 10.1016/j.eucr.2016.06.005. eCollection 2016 Sep. PMID: 27500086; PMCID: PMC4968184.
Copy Download .nbib Format: NLM
The Use of a Novel Heart Failure Agent in the Treatment of Pregnancy-Associated Cardiomyopathy.

Case reports in cardiology

Gaddipati VC, Patel AA, Cohen AJ.
PMID: 28890834
Case Rep Cardiol. 2017;2017:9561405. doi: 10.1155/2017/9561405. Epub 2017 Aug 14.

Peripartum cardiomyopathy is an uncommon, pregnancy-related form of dilated cardiomyopathy that is associated with development of new-onset left ventricular dysfunction. Its etiology is presently unknown, but current standard of care involves the use of typical drug therapy for the...

Cite
Gaddipati VC, Patel AA, Cohen AJ. The Use of a Novel Heart Failure Agent in the Treatment of Pregnancy-Associated Cardiomyopathy. Case Rep Cardiol. 2017;2017:9561405doi: 10.1155/2017/9561405.
Gaddipati, V. C., Patel, A. A., & Cohen, A. J. (2017). The Use of a Novel Heart Failure Agent in the Treatment of Pregnancy-Associated Cardiomyopathy. Case reports in cardiology, 20179561405. https://doi.org/10.1155/2017/9561405
Gaddipati, Vamsi C, et al. "The Use of a Novel Heart Failure Agent in the Treatment of Pregnancy-Associated Cardiomyopathy." Case reports in cardiology vol. 2017 (2017): 9561405. doi: https://doi.org/10.1155/2017/9561405
Gaddipati VC, Patel AA, Cohen AJ. The Use of a Novel Heart Failure Agent in the Treatment of Pregnancy-Associated Cardiomyopathy. Case Rep Cardiol. 2017;2017:9561405. doi: 10.1155/2017/9561405. Epub 2017 Aug 14. PMID: 28890834; PMCID: PMC5584348.
Copy Download .nbib Format: NLM
Poster 71 New Frontiers: Inpatient Comprehensive Rehabilitation After Full Face Transplantation: A Case Report.

PM & R : the journal of injury, function, and rehabilitation

McKay TE, Balou M, Kao DJ, Ho DJ, Cohen J, Rodriguez ED.
PMID: 27672839
PM R. 2016 Sep;8(9):S184. doi: 10.1016/j.pmrj.2016.07.114. Epub 2016 Sep 24.

No abstract available.

Cite
McKay TE, Balou M, Kao DJ, et al. Poster 71 New Frontiers: Inpatient Comprehensive Rehabilitation After Full Face Transplantation: A Case Report. PM R. 2016;8(9):S184doi: 10.1016/j.pmrj.2016.07.114.
McKay, T. E., Balou, M., Kao, D. J., Ho, D. J., Cohen, J., & Rodriguez, E. D. (2016). Poster 71 New Frontiers: Inpatient Comprehensive Rehabilitation After Full Face Transplantation: A Case Report. PM & R : the journal of injury, function, and rehabilitation, 8(9), S184. https://doi.org/10.1016/j.pmrj.2016.07.114
McKay, Tracy Espiritu, et al. "Poster 71 New Frontiers: Inpatient Comprehensive Rehabilitation After Full Face Transplantation: A Case Report." PM & R : the journal of injury, function, and rehabilitation vol. 8,9 (2016): S184. doi: https://doi.org/10.1016/j.pmrj.2016.07.114
McKay TE, Balou M, Kao DJ, Ho DJ, Cohen J, Rodriguez ED. Poster 71 New Frontiers: Inpatient Comprehensive Rehabilitation After Full Face Transplantation: A Case Report. PM R. 2016 Sep;8(9):S184. doi: 10.1016/j.pmrj.2016.07.114. Epub 2016 Sep 24. PMID: 27672839.
Copy Download .nbib Format: NLM
Epstein-barr virus vaccines.

Clinical & translational immunology

Cohen JI.
PMID: 25671130
Clin Transl Immunology. 2015 Jan 23;4(1):e32. doi: 10.1038/cti.2014.27. eCollection 2015 Jan.

Epstein-Barr virus (EBV) is the primary cause of infectious mononucleosis (IM) and is associated with epithelial cell malignancies such as nasopharyngeal carcinoma and gastric carcinoma, as well as lymphoid malignancies including Hodgkin lymphoma, Burkitt lymphoma, non-Hodgkin lymphoma and post-transplant...

Cite
Cohen JI. Epstein-barr virus vaccines. Clin Transl Immunology. 2015;4(1):e32doi: 10.1038/cti.2014.27.
Cohen, J. I. (2015). Epstein-barr virus vaccines. Clinical & translational immunology, 4(1), e32. https://doi.org/10.1038/cti.2014.27
Cohen, Jeffrey I. "Epstein-barr virus vaccines." Clinical & translational immunology vol. 4,1 (2015): e32. doi: https://doi.org/10.1038/cti.2014.27
Cohen JI. Epstein-barr virus vaccines. Clin Transl Immunology. 2015 Jan 23;4(1):e32. doi: 10.1038/cti.2014.27. eCollection 2015 Jan. PMID: 25671130; PMCID: PMC4318489.
Copy Download .nbib Format: NLM
Robustness of Type I Error and Power in Set Correlation Analysis of Contingency Tables.

Multivariate behavioral research

Cohen J, Nee JC.
PMID: 26761408
Multivariate Behav Res. 1990 Jul 01;25(3):341-50. doi: 10.1207/s15327906mbr2503_6.

The analysis of contingency tables by means of set correlation makes possible the assessment of sub-hypotheses involving contrast functions of the categories of the nominal scales. This follow-up analysis of the overall association provides greater interpretive yield than do...

Cite
Cohen J, Nee JC. Robustness of Type I Error and Power in Set Correlation Analysis of Contingency Tables. Multivariate Behav Res. 1990;25(3):341-50doi: 10.1207/s15327906mbr2503_6.
Cohen, J., & Nee, J. C. (1990). Robustness of Type I Error and Power in Set Correlation Analysis of Contingency Tables. Multivariate behavioral research, 25(3), 341-50. https://doi.org/10.1207/s15327906mbr2503_6
Cohen, J, and Nee, J C. "Robustness of Type I Error and Power in Set Correlation Analysis of Contingency Tables." Multivariate behavioral research vol. 25,3 (1990): 341-50. doi: https://doi.org/10.1207/s15327906mbr2503_6
Cohen J, Nee JC. Robustness of Type I Error and Power in Set Correlation Analysis of Contingency Tables. Multivariate Behav Res. 1990 Jul 01;25(3):341-50. doi: 10.1207/s15327906mbr2503_6. PMID: 26761408.
Copy Download .nbib Format: NLM
"It gives them more options": preferences for preconception genetic carrier screening for fragile X syndrome in primary healthcare.

Journal of community genetics

Archibald AD, Hickerton CL, Wake SA, Jaques AM, Cohen J, Metcalfe SA.
PMID: 26842720
J Community Genet. 2016 Apr;7(2):159-71. doi: 10.1007/s12687-016-0262-8. Epub 2016 Feb 03.

This study aims to explore stakeholder views about offering population-based genetic carrier screening for fragile X syndrome. A qualitative study using interviews and focus groups with stakeholders was undertaken to allow for an in-depth exploration of views and perceptions...

Cite
Archibald AD, Hickerton CL, Wake SA, et al. "It gives them more options": preferences for preconception genetic carrier screening for fragile X syndrome in primary healthcare. J Community Genet. 2016;7(2):159-71doi: 10.1007/s12687-016-0262-8.
Archibald, A. D., Hickerton, C. L., Wake, S. A., Jaques, A. M., Cohen, J., & Metcalfe, S. A. (2016). "It gives them more options": preferences for preconception genetic carrier screening for fragile X syndrome in primary healthcare. Journal of community genetics, 7(2), 159-71. https://doi.org/10.1007/s12687-016-0262-8
Archibald, Alison D, et al. ""It gives them more options": preferences for preconception genetic carrier screening for fragile X syndrome in primary healthcare." Journal of community genetics vol. 7,2 (2016): 159-71. doi: https://doi.org/10.1007/s12687-016-0262-8
Archibald AD, Hickerton CL, Wake SA, Jaques AM, Cohen J, Metcalfe SA. "It gives them more options": preferences for preconception genetic carrier screening for fragile X syndrome in primary healthcare. J Community Genet. 2016 Apr;7(2):159-71. doi: 10.1007/s12687-016-0262-8. Epub 2016 Feb 03. PMID: 26842720; PMCID: PMC4796042.
Copy Download .nbib Format: NLM
Transfer Delays From the Neurologic Intensive Care Unit: A Prospective Cohort Study.

The Neurohospitalist

Morris NA, Batra A, Biffi A, Cohen AB.
PMID: 27053982
Neurohospitalist. 2016 Apr;6(2):59-63. doi: 10.1177/1941874415603426. Epub 2015 Sep 08.

INTRODUCTION: Neurocritical care beds are a scarce, valuable resource. The purpose of this pilot study was to quantify discharge delays from the neurologic intensive care unit (NICU) at a tertiary-care teaching hospital and to examine the impact on overall...

Cite
Morris NA, Batra A, Biffi A, et al. Transfer Delays From the Neurologic Intensive Care Unit: A Prospective Cohort Study. Neurohospitalist. 2015;6(2):59-63doi: 10.1177/1941874415603426.
Morris, N. A., Batra, A., Biffi, A., & Cohen, A. B. (2016). Transfer Delays From the Neurologic Intensive Care Unit: A Prospective Cohort Study. The Neurohospitalist, 6(2), 59-63. https://doi.org/10.1177/1941874415603426
Morris, Nicholas A, et al. "Transfer Delays From the Neurologic Intensive Care Unit: A Prospective Cohort Study." The Neurohospitalist vol. 6,2 (2016): 59-63. doi: https://doi.org/10.1177/1941874415603426
Morris NA, Batra A, Biffi A, Cohen AB. Transfer Delays From the Neurologic Intensive Care Unit: A Prospective Cohort Study. Neurohospitalist. 2016 Apr;6(2):59-63. doi: 10.1177/1941874415603426. Epub 2015 Sep 08. PMID: 27053982; PMCID: PMC4802774.
Copy Download .nbib Format: NLM
The Tobacco Pack Surveillance System: A Protocol for Assessing Health Warning Compliance, Design Features, and Appeals of Tobacco Packs Sold in Low- and Middle-Income Countries.

JMIR public health and surveillance

Smith K, Washington C, Brown J, Vadnais A, Kroart L, Ferguson J, Cohen J.
PMID: 27227142
JMIR Public Health Surveill. 2015 Aug 12;1(2):e8. doi: 10.2196/publichealth.4616. eCollection 2015.

BACKGROUND: Tobacco remains the world's leading preventable cause of death, with the majority of tobacco-caused deaths occurring in low- and middle-income countries. The first global health treaty, the Framework Convention on Tobacco Control (FCTC), outlines a set of policy...

Cite
Smith K, Washington C, Brown J, et al. The Tobacco Pack Surveillance System: A Protocol for Assessing Health Warning Compliance, Design Features, and Appeals of Tobacco Packs Sold in Low- and Middle-Income Countries. JMIR Public Health Surveill. 2015;1(2):e8doi: 10.2196/publichealth.4616.
Smith, K., Washington, C., Brown, J., Vadnais, A., Kroart, L., Ferguson, J., & Cohen, J. (2015). The Tobacco Pack Surveillance System: A Protocol for Assessing Health Warning Compliance, Design Features, and Appeals of Tobacco Packs Sold in Low- and Middle-Income Countries. JMIR public health and surveillance, 1(2), e8. https://doi.org/10.2196/publichealth.4616
Smith, Katherine, et al. "The Tobacco Pack Surveillance System: A Protocol for Assessing Health Warning Compliance, Design Features, and Appeals of Tobacco Packs Sold in Low- and Middle-Income Countries." JMIR public health and surveillance vol. 1,2 (2015): e8. doi: https://doi.org/10.2196/publichealth.4616
Smith K, Washington C, Brown J, Vadnais A, Kroart L, Ferguson J, Cohen J. The Tobacco Pack Surveillance System: A Protocol for Assessing Health Warning Compliance, Design Features, and Appeals of Tobacco Packs Sold in Low- and Middle-Income Countries. JMIR Public Health Surveill. 2015 Aug 12;1(2):e8. doi: 10.2196/publichealth.4616. eCollection 2015. PMID: 27227142; PMCID: PMC4869212.
Copy Download .nbib Format: NLM
Showing 13 to 24 of 1532 entries